• 1
    Centers for Disease Control and Prevention. Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices—Ohio and New York City, 1996. MMWR Morb Mortal Wkly Rep 1997;46:217221.
  • 2
    Quale JM, Landman D, Wallace B et al. Déjà vu: Nosocomial hepatitis B virus transmission and fingerstick monitoring. Am J Med 1998;105:296301.
  • 3
    Centers for Disease Control and Prevention. Transmission of hepatitis B virus among persons undergoing blood-glucose monitoring in long-term care facilities—Mississippi, North Carolina, and Los Angeles County, California, 2003–2004. MMWR Morb Mortal Wkly Rep 2005;54:220223 Located at
  • 4
    Thompson ND, Perz JF, Moorman AC et al. Nonhospital health care–associated hepatitis B and C virus transmission: United States, 1998–2008. Ann Intern Med 2009;150:3339.
  • 5
    Centers for Disease Control and Prevention. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Morb Mortal Wkly Rep 2001;50 (No. RR-11):37.
  • 6
    American Association of Diabetes Educators. Prevention of transmission of blood-borne infectious agents during blood-glucose monitoring. Diabetes Educator 1988;14:425426.
  • 7
    Bond WW, Favero MS, Petersen NJ et al. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;i:550551.
  • 8
    Patel AS, White-Comstock MB, Woolard CD et al. Infection Control practices in assisted living facilities: a response to hepatitis B virus infection outbreaks. Infect Control Hosp Epidemiol 2009;30:209214.
  • 9
    Sikorska-Simmons E. Predictors of organizational commitment among staff in assisted living. Gerontologist 2005;45:196205.
  • 10
    Kovner CT, Harrington C. CMS study: Correlation between staffing and quality [NursingCounts column]. Am J Nurs 2002;102:6566.
  • 11
    Perz JF, Fiore AE. Preventing the transmission of bloodborne viruses during glucose monitoring: Lessons learned from recent outbreaks [Letter]. J Am Med Dir Assoc 2006;7:6566.
  • 12
    Perz JF, Fiore AE. Hepatitis B virus infection risks among diabetic patients residing in long-term care facilities. Clin Infect Dis 2005;41:760761.
  • 13
    Götz HM, Schutten M, Borsboom GJ et al. A cluster of hepatitis B infections associated with incorrect use of a capillary blood sampling device in a nursing home in the Netherlands, 2007. Euro Surveillance 2008;13:14. Located at
  • 14
    Thompson ND, Perz JF. Eliminating the blood: Ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol 2009;3:283288.
  • 15
    Khan AJ, Cotter SM, Schultz B et al. Nosocomial transmission of hepatitis B virus infection among residents with diabetes in a skilled nursing facility. Infect Control Hosp Epidemiol 2002;23:313318.
  • 16
    Louie RF, Lau MJ, Lee JH et al. Multicenter study of the prevalence of blood contamination on point-of-care glucose meters and recommendations for controlling contamination. Point of Care 2005;4:158163.
  • 17
    American Association of Diabetes Educators. Educating Providers and Persons with Diabetes to Prevent the Transmission of bloodborne Infections and Avoid Injuries from Sharps. Position Statement 1997 [on-line]. Available at Accessed June 10, 2007.
  • 18
    Centers for Disease Control and Prevention. Recommended infection-control and safe injection practices to prevent patient-to-patient transmission of bloodborne pathogens. MMWR Morb Mortal Wkly Rep 2005;54:220223. Located at